The Use of Anabolic Androgenic Steroids: A Focus on Polypharmacy
January 2018
in “
Medicinski pregled
”
TLDR Using high doses and multiple drugs with steroids is risky and should be prevented.
The document discussed the nonmedical use of anabolic androgenic steroids (AAS) like testosterone and nandrolone, particularly in the context of polypharmacy, where users combine these steroids with other pharmacological agents to enhance physical performance and manage side effects. This practice was prevalent among various social groups, including athletes and individuals involved in criminal activities. The combination of AAS with substances like growth hormone, insulin, clenbuterol, and diuretics aimed to boost anabolic effects, reduce body fat, and improve muscle definition, while other drugs were used to mask doping or manage adverse effects. The document highlighted the increased risk of adverse effects and withdrawal syndrome due to supraphysiological doses and polypharmacy, emphasizing the need for public health measures to prevent the nonmedical use of AAS.